CDY 1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-643

  1. 356 Posts.
    lightbulb Created with Sketch. 56
    Brilliant analysis Pharma;

    I would rather be invested in a company with an under valued share price with real products + real science + real revenue + real potential + real deals than...

    one with overly inflated share price with no revenue + no guidance + pure speculation + high cash burn + awaiting drill results + cyclical sentiment
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.